Current and extended durations of non-aspirin use appeared associated with an increased risk for fatal renal cell carcinoma, according to study results.
The findings, presented during American Association for Cancer Research Annual Meeting, showed prediagnostic acetaminophen use specifically among men positively correlated with fatal renal cell carcinoma.
“Data have demonstrated an association between the and an increased risk for renal cell carcinoma, while other data have not demonstrated a relationship,” Rebecca E. Graff, ScD, assistant professor in the department of epidemiology